This site is intended for healthcare professionals

Multiple Sclerosis News 1/2020 Czech edition

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a

Eva Havrdová, Douglas L Arnold, Amit Bar-Or, Giancarlo Comi, Hans-Peter Hartung, Ludwig Kappos, Fred Lublin, Krzysztof Selmaj, Anthony Traboulsee, Shibeshih Belachew, Iain Bennett, Regine Buffels, Hideki Garren, Jian Han, Laura Julian, Julie Napieralski, Stephen L Hauser, Gavin Giovannoni

Multiple Sclerosis News 1/2020 Czech edition

Keywords: NEDA, disease activity, relapse, disability progression, MRI activity   Background No evidence of disease activity (NEDA; defined as no 12-week confirmed disability progression, no protocol-defined relapses, no new/enlarging T2 lesions and no T1 gadolini­um enhancing lesions) using a fixed-study entry baseline is commonly used as a treatment outcome in multiple sclerosis (MS).   Objective…

Zpět

Ortopedie a traumatologie nohy a hlezna dospělého věku

19 | 09 | 2025

V těchto dnech vychází již 6. svazek Albertovy sbírky.

HOME Journal 2/2025

17 | 09 | 2025

Právě vyšlo nové číslo časopisu HOME Journal.

Cystická fibróza 1/2025

02 | 07 | 2025

V červenci vyjde první letošní číslo časopisu Cystická fibróza.




Partneři projektu